RxDoctor Payments Data

Ellen Rakhman

Family · Chicago, ILNPI 1215575402

Payments from drug & device makers

$6,481in general payments, 2019–2025

Across 330 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$912
  • Lilly USA, LLC$410
  • AstraZeneca$375
  • Bayer$335
  • Mylan Specialty L.p.$333
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$6,481100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,481 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$58,150
Medicare patients
256
Services billed
986

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$45,306
JanuviaSitagliptin Phosphate42$37,336
FarxigaDapagliflozin Propanediol32$35,373
TradjentaLinagliptin29$24,726
JardianceEmpagliflozin25$18,770
EliquisApixaban24$15,268
LinzessLinaclotide18$12,287
TrulicityDulaglutide12$11,318
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,744
VascepaIcosapent Ethyl12$4,920
Fluticasone-VilanterolFluticasone/Vilanterol14$4,571
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen144$3,658
Albuterol Sulfate HfaAlbuterol Sulfate111$3,421
Icosapent Ethyl14$2,498
Diclofenac Sodium104$2,336

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$375$46,11749 claims
Novo NordiskOzempic$912$45,30645 claims
Boehringer IngelheimTradjenta, Jardiance$129$43,49654 claims
MerckJanuvia$61$37,33642 claims
PfizerEliquis$113$15,26824 claims
AbbVieLinzess$1,180$12,28718 claims
Lilly USA, LLCTrulicity$410$11,31812 claims
Scilex Pharmaceuticals Inc.Colchicine$68$1,64729 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.

Other family in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →